Cardiovascular risk factors cause cortical thinning in cognitively impaired patients: Relationships among cardiovascular risk factors, white matter hyperintensities, and cortical atrophy

Alzheimer Disease and Associated Disorders

Volumn 26, Issue 2, 2012, Pages 106-112

  Seo, Sang Won ^a   Lee, Jong Min ^b   Im, Kiho ^h   Park, Jun Sung ^b   Kim, Sook Hui ^c   Kim, Sung Tae ^a   Ahn, Joong Hyun ^d   Kim, Min Jeong ^e   Kim, Geon Ha ^a   Kim, Jong Hun ^f   Roh, Jee Hoon ^a   Cheong, Hae Kwan ^g   Na, Duk L ^a  

^a Sungkyunkwan University   (South Korea)

^b Hanyang University   (South Korea)

^c Konkuk University Hospital   (South Korea)

^d Samsung Medical Center   (South Korea)

^e Seoul National University Boramae Hospital   (South Korea)

^f National Health Insurance Corporation   (South Korea)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

cortical thickness; diabetes mellitus; hyperlipidemia; hypertension; white matter hyperintensities

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX ATROPHY; BRAIN REGION; BRAIN SIZE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FRONTAL LOBE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMAGE PROCESSING; INFERIOR FRONTAL GYRUS; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CINGULATE; PRIORITY JOURNAL; SUPRASYLVIAN GYRUS; TEMPORAL LOBE; WHITE MATTER;

AGED; AGED, 80 AND OVER; ATROPHY; BRAIN; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEMENTIA, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84861458636     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31822e0831     Document Type: Article

References (40)

1. Roman GC., Erkinjuntti T., Wallin A., et al. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426-436. (Pubitemid 37159153)
2. Duron E., Hanon O. Vascular risk factors., cognitive decline., and dementia. Vasc Health Risk Manag. 2008;4:363-381. (Pubitemid 351711965)
3. Petrovitch H., White LR., Izmirilian G., et al. Midlife blood pressure and neuritic plaques., neurofibrillary tangles., and brain weight at death: the HAAS. Honolulu-Asia aging study. Neurobiol Aging. 2000;21:57-62. (Pubitemid 30224786)
4. Peila R., Rodriguez BL., Launer LJ. Type 2 diabetes., APOE gene., and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes. 2002;51:1256-1262. (Pubitemid 34438377)
5. Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000;21:153-160. (Pubitemid 30387074)
6. Lerch JP., Pruessner JC., Zijdenbos A., et al. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb Cortex. 2005;15:995-1001. (Pubitemid 40848068)
7. Seo SW., Ahn J., Yoon U., et al. Cortical thinning in vascular mild cognitive impairment and vascular dementia of subcortical type. J Neuroimaging. 2010;20:37-45.
8. Pantel J., Schroder J., Essig M., et al. In vivo quantification of brain volumes in subcortical vascular dementia and Alzheimer's disease: an MRI-based study. Dement Geriatr Cogn Disord. 1998;9:309-316. (Pubitemid 28479472)
9. Fein G., Di Sclafani V., Tanabe J., et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 2000;55:1626-1635.
10. Gianaros PJ., Greer PJ., Ryan CM., et al. Higher blood pressure predicts lower regional grey matter volume: consequences on short-term information processing. Neuroimage. 2006;31: 754-765. (Pubitemid 43776680)
11. Brundel M., van den Heuvel M., de Bresser J., et al. Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci. 2010;299:126-130.
12. Wessels AM., Simsek S., Remijnse PL., et al. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia. 2006;49:2474-2480. (Pubitemid 44359110)
13. Baker LD., Cross DJ., Minoshima S., et al. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol. 2011;68: 51-57.
14. Liao D., Cooper L., Cai J., et al. The prevalence and severity of white matter lesions., their relationship with age., ethnicity., gender., and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology. 1997;16:149-162. (Pubitemid 27215864)
15. Seo SW., Cho SS., Park A., et al. Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism. J Neuroimaging. 2009;19:213-219.
16. Knopman DS., Mosley TH., Catellier DJ., et al. Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology. 2005;65:876-881. (Pubitemid 41362133)
17. Du AT., Schuff N., Chao LL., et al. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging. 2005;26:553-559. (Pubitemid 40093938)
18. Seo SW., Lee JM., Im K., et al. Cortical thinning related to periventricular and deep white matter hyperintensities. NeurobiolAging. 2011. [Epub ahead of print].
19. Petersen RC., Smith GE., Waring SC., et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
20. Kim MJ., Im K., Lee JM., et al. Cortical thinning in verbal., visual., and both memory-predominant mild cognitive impairment. Alzheimer Dis Assoc Disord. 2011;25:242-249.
21. McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944. (Pubitemid 14076461)
22. Erkinjuntti T., Inzitari D., Pantoni L., et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl. 2000;59:23-30. (Pubitemid 30479402)
23. Seo SW., Im K., Lee JM., et al. Cortical thickness in singleversus multiple-domain amnestic mild cognitive impairment. Neuroimage. 2007;36:289-297. (Pubitemid 46710453)
24. Kim JS., Singh V., Lee JK., et al. Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. Neuroimage. 2005;27:210-221. (Pubitemid 40966896)
25. Im K., Lee JM., Lee J., et al. Gender difference analysis of cortical thickness in healthy young adults with surface-based methods. Neuroimage. 2006;31:31-38. (Pubitemid 43728982)
26. Lyttelton O., Boucher M., Robbins S., et al. An unbiased iterative group registration template for cortical surface analysis. Neuroimage. 2007;34:1535-1544. (Pubitemid 46187067)
27. Genovese CR., Lazar NA., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage. 2002;15:870-878. (Pubitemid 34852500)
28. Raz N., Rodrigue KM., Acker JD. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav Neurosci. 2003;117:1169-1180. (Pubitemid 37549420)
29. Knopman D., Boland LL., Mosley T., et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42-48. (Pubitemid 32059650)
30. Stewart R., Liolitsa D. Type 2 diabetes mellitus., cognitive impairment and dementia. Diabet Med. 1999;16:93-112.
31. Kivipelto M., Helkala EL., Laakso MP., et al. Apolipoprotein E epsilon4 allele., elevated midlife total cholesterol level., and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002;137:149-155. (Pubitemid 34827510)
32. Tan ZS., Seshadri S., Beiser A., et al. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med. 2003;163:1053-1057. (Pubitemid 36548931)
33. Ginsberg SD., Martin LJ. Axonal transection in adult rat brain induces transsynaptic apoptosis and persistent atrophy of target neurons. J Neurotrauma. 2002;19:99-109. (Pubitemid 34117099)
34. Johnson H., Cowey A. Transneuronal retrograde degeneration of retinal ganglion cells following restricted lesions of striate cortex in the monkey. Exp Brain Res. 2000;132: 269-275. (Pubitemid 30261340)
35. Lin B., Ginsberg MD., Busto R. Hyperglycemic exacerbation of neuronal damage following forebrain ischemia: microglial., astrocytic and endothelial alterations. Acta Neuropathol. 1998; 96:610-620. (Pubitemid 28517655)
36. Kemper T., Moss MB., Hollander W., et al. Microinfarction as a result of hypertension in a primate model of cerebrovascular disease. Acta Neuropathol. 1999;98:295-303. (Pubitemid 29396862)
37. Jellinger KA. The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol. 2007;113:349-388. (Pubitemid 46421627)
38. Kovari E., Gold G., Herrmann FR., et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke. 2004;35:410-414. (Pubitemid 38174421)
39. Maclullich AM., Ferguson KJ., Reid LM., et al. Higher systolic blood pressure is associated with increased water diffusivity in normal-appearing white matter. Stroke. 2009;40:3869-3871.
40. Korf ES., van Straaten EC., de Leeuw FE., et al. Diabetes mellitus., hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med. 2007;24:166-171. (Pubitemid 46174940)